These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35393273)

  • 1. Copper-histidine therapy in an infant with novel splice-site variant in the
    Panichsillaphakit E; Kwanbunbumpen T; Chomtho S; Visuthranukul C
    BMJ Case Rep; 2022 Apr; 15(4):. PubMed ID: 35393273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mutations and clinical outcomes of copper-histidine therapy in Menkes disease patients.
    Kim JH; Lee BH; Kim YM; Choi JH; Kim GH; Cheon CK; Yoo HW
    Metab Brain Dis; 2015 Feb; 30(1):75-81. PubMed ID: 24919650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The T1048I mutation in ATP7A gene causes an unusual Menkes disease presentation.
    León-García G; Santana A; Villegas-Sepúlveda N; Pérez-González C; Henrríquez-Esquíroz JM; de León-García C; Wong C; Baeza I
    BMC Pediatr; 2012 Sep; 12():150. PubMed ID: 22992316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In utero copper treatment for Menkes disease associated with a severe ATP7A mutation.
    Haddad MR; Macri CJ; Holmes CS; Goldstein DS; Jacobson BE; Centeno JA; Popek EJ; Gahl WA; Kaler SG
    Mol Genet Metab; 2012 Sep; 107(1-2):222-8. PubMed ID: 22695177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menkes disease: importance of diagnosis with molecular analysis in the neonatal period.
    Costa LS; Pegler SP; Lellis RF; Krebs VL; Robertson S; Morgan T; Honjo RS; Bertola DR; Kim CA
    Rev Assoc Med Bras (1992); 2015; 61(5):407-10. PubMed ID: 26603002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Truncating De Novo Point Mutation in a Young Infant with Severe Menkes Disease.
    Lin YJ; Ho CS; Hsu CH; Lin JL; Chuang CK; Tsai JD; Chiu NC; Lin HY; Lin SP
    Pediatr Neonatol; 2017 Feb; 58(1):89-92. PubMed ID: 25771438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menkes disease and infantile epilepsy.
    Prasad AN; Levin S; Rupar CA; Prasad C
    Brain Dev; 2011 Nov; 33(10):866-76. PubMed ID: 21924848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal erythroderma as a first manifestation of Menkes disease.
    Galve J; Vicente A; González-Enseñat MA; Pérez-Dueñas B; Cusí V; Møller LB; Julià M; Domínguez A; Ferrando J
    Pediatrics; 2012 Jul; 130(1):e239-42. PubMed ID: 22711717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and ATP7A gene analysis of three infants with Menkes disease and prenatal diagnosis for a fetus at risk].
    Wang Q; Ding Y; Wang JM; Huang QH; Zhao CF; Liu YP; Li XY; Wu TF; Song JQ; Wang YJ; Yang YL
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jun; 16(6):624-8. PubMed ID: 24927440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menkes disease mutations and response to early copper histidine treatment.
    Kaler SG
    Nat Genet; 1996 May; 13(1):21-2. PubMed ID: 8673098
    [No Abstract]   [Full Text] [Related]  

  • 11. Neurodevelopment and brain growth in classic Menkes disease is influenced by age and symptomatology at initiation of copper treatment.
    Kaler SG
    J Trace Elem Med Biol; 2014 Oct; 28(4):427-30. PubMed ID: 25281031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes in Menkes disease patients with a copper-responsive ATP7A mutation, G727R.
    Tang J; Donsante A; Desai V; Patronas N; Kaler SG
    Mol Genet Metab; 2008 Nov; 95(3):174-81. PubMed ID: 18752978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular correlates of epilepsy in early diagnosed and treated Menkes disease.
    Kaler SG; Liew CJ; Donsante A; Hicks JD; Sato S; Greenfield JC
    J Inherit Metab Dis; 2010 Oct; 33(5):583-9. PubMed ID: 20652413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menkes disease.
    Tümer Z; Møller LB
    Eur J Hum Genet; 2010 May; 18(5):511-8. PubMed ID: 19888294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Menkes' disease: heterozygosity testing by quantitative real-time PCR and the dilemma of therapeutic support].
    Rittinger O; Sander G; Schaller A; Gallati S; Mayr H; Sperl W
    Klin Padiatr; 2005; 217(5):286-90. PubMed ID: 16167277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of clinical features and genetic mutations in a Chinese family affected with Menkes disease].
    Shi X; Lin X; Ke Z; Chen S; Wu B; Mo G
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Apr; 34(2):220-223. PubMed ID: 28397223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical manifestations of Menkes disease vary according to patient's genotype and the initiation time of treatment with copper-histidine injections].
    Yagi M; Kusunoki N; Lee T; Awano H; Kodama H; Takeshima Y; Iijima K
    No To Hattatsu; 2014 May; 46(3):227-8. PubMed ID: 24902345
    [No Abstract]   [Full Text] [Related]  

  • 18. Mutation in the CPC motif-containing 6th transmembrane domain affects intracellular localization, trafficking and copper transport efficiency of ATP7A protein in mosaic mutant mice--an animal model of Menkes disease.
    Lenartowicz M; Grzmil P; Shoukier M; Starzyński R; Marciniak M; Lipiński P
    Metallomics; 2012 Feb; 4(2):197-204. PubMed ID: 22089129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [From gene to disease; Menkes disease: copper deficiency due to an ATP7A-gene defect].
    Aldenhoven M; Klomp LW; van Hasselt PM; de Koning TJ; Visser G
    Ned Tijdschr Geneeskd; 2007 Oct; 151(41):2266-70. PubMed ID: 17987894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in the expression of the Atp7a gene in the early postnatal development of the mosaic mutant mice (Atp7a mo-ms) - An animal model for Menkes disease.
    Lenartowicz M; Starzyński R; Wieczerzak K; Krzeptowski W; Lipiński P; Styrna J
    Gene Expr Patterns; 2011; 11(1-2):41-7. PubMed ID: 20831904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.